SPDR® S&P Biotech ETF (XBI) — Technical state
As of 2026-10-12 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
Trades -4.4% vs the 50-day and +8.5% vs the 200-day average, 10.9% below the 52-week high and +48.1% off the 52-week low. Computed from daily closes.
Ranked #4 on today’s Directional Flow — theme flow list (scan of 2026-10-12).
The moving-average stack
- vs 20-day-2.4%
- vs 50-day-4.4%
- vs 200-day+8.5%
- 52-week band10.9% off the high · +48.1% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed down through the 50-day 13 sessions ago
- Stochastic%K 32.3 · %D 25.9
Continue: the XBI chart & overview · the signal board
FAQ · from the current data · as of 2026-10-12
Quick answers
What is the current Closelooknet signal on XBI?
Pullback inside an uptrend stack — Trades -4.4% vs the 50-day and +8.5% vs the 200-day average, 10.9% below the 52-week high and +48.1% off the 52-week low. Computed from daily closes. As of 2026-10-12; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is XBI above its 50-day and 200-day moving averages?
As of 2026-10-12, SPDR® S&P Biotech ETF trades -4.4% below its 50-day and +8.5% above its 200-day average, with the 20-day -2.4% away.
How far is XBI from its 52-week high?
10.9% below the 52-week high and 48.1% above the 52-week low, as of 2026-10-12.
Mentioned on Closelooknet
Where XBI appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Long reads
- Treasuries — Stock Market at a Crossroads
Among the leading-indicator basket — KRE, XHB, IGV, XBI, IWM — the homebuilders ETF delivered the sharpest single message of the week.